Core Viewpoint - OssaNova, a product of Aojing Medical, has received registration certification in Vietnam, which is expected to aid the company's expansion into overseas markets, although the specific impact on performance remains uncertain [1][3]. Company Announcements Summary - Aojing Medical has announced that its artificial bone repair material received registration certification from the Vietnamese Ministry of Health, effective from July 16, 2025, with a permanent validity [3]. - The registration number for the product is 2502543ĐKLH/BYT-HTTB, classified as a Class D (high-risk medical device) [3]. - The OssaNova artificial bone repair material is primarily used for bone defect repair in oral or plastic surgery where there are no contraindications for bone grafting, and it has previously received registration in China and Indonesia [3]. - The company has decided to cancel its fundraising account at Industrial Bank due to adjustments in the implementation subject and location of fundraising projects, with the cancellation date set for July 23, 2025 [2][3]. - The termination of the related four-party regulatory agreement has been communicated to the sponsor institution Huatai United and the sponsoring representative [3].

奥精医疗公告，公司于2024年12月向越南卫生部递交了人工骨修复材料的注册申报资料，近日收到通 知，该材料获得批准。OssaNova 人工骨修复材料是基于公司具有完全自主知识产权的体外仿生矿化技 术研发和生产的一种仿生矿化胶原人工骨修复材料。产品用于口腔科或整形外科无植骨禁忌的骨缺损修 复，植入体内后能够在引导骨再生的同时被新生骨组织爬行替代。本次公司产品在越南获得注册证，是 公司海外业务拓展的重要组成部分，将对公司产品在海外的销售起到一定的推动和促进作用。 ...